Medical Director, Medical Oncology ICU Wake Forest Baptist Medical Center Winston-Salem, North Carolina
Disclosure(s):
Peter Miller, MD: No relevant financial relationship(s) to disclose.
After a few months following Allogenic HSCTÂ may be at risk for developing a range of infectious and noninfectious complications that are unique to this setting. The speaker is to provide an initial approach to the differential diagnosis when managing these patients in the setting of critical illness
